Nick Wadd

770 total citations
10 papers, 83 citations indexed

About

Nick Wadd is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nick Wadd has authored 10 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Nick Wadd's work include Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Nick Wadd is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Nick Wadd collaborates with scholars based in United Kingdom and Germany. Nick Wadd's co-authors include H.H. Lucraft, Y K S Viswanath, Michel Seymour, MJ McDonnell, Anjan Dhar, D. Rea, Gary Middleton, Henry Marshall, F. Adab and Alfred Oliver and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Nick Wadd

10 papers receiving 81 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nick Wadd United Kingdom	5	45	30	28	16	12	10	83
Nathania Sutandi Indonesia	5	50 1.1×	35 1.2×	40 1.4×	9 0.6×	12 1.0×	8	83
Henk van Halteren Netherlands	5	40 0.9×	14 0.5×	20 0.7×	19 1.2×	8 0.7×	8	98
Sonia Mansukhani United Kingdom	4	25 0.6×	28 0.9×	21 0.8×	23 1.4×	5 0.4×	6	63
A. Poveda Velasco Spain	6	21 0.5×	37 1.2×	31 1.1×	11 0.7×	9 0.8×	8	112
Carlos Adame United States	4	29 0.6×	42 1.4×	13 0.5×	4 0.3×	9 0.8×	7	58
Yuta Maruki Japan	8	78 1.7×	97 3.2×	109 3.9×	11 0.7×	5 0.4×	47	160
Guole Lin China	7	90 2.0×	29 1.0×	68 2.4×	8 0.5×	8 0.7×	27	142
Maurizio Ronconi Italy	6	21 0.5×	54 1.8×	72 2.6×	5 0.3×	4 0.3×	15	124
Teresa Perra Italy	6	64 1.4×	49 1.6×	77 2.8×	10 0.6×	4 0.3×	12	123
Aurélie Scriva France	4	51 1.1×	38 1.3×	19 0.7×	19 1.2×	1 0.1×	5	64

Countries citing papers authored by Nick Wadd

Since Specialization

Citations

This map shows the geographic impact of Nick Wadd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Wadd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Wadd more than expected).

Fields of papers citing papers by Nick Wadd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Wadd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Wadd. The network helps show where Nick Wadd may publish in the future.

Co-authorship network of co-authors of Nick Wadd

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Wadd. A scholar is included among the top collaborators of Nick Wadd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Wadd. Nick Wadd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wadd, Nick, et al.. (2025). 45P Real life comparison of toxicity from cetuximab and panitumumab in the first-line treatment of metastatic colorectal cancer. Annals of Oncology. 36. S27–S28. 1 indexed citations

Wadd, Nick, et al.. (2022). Real-World Assessment of Cancer Drugs Using Local Data Uploaded to the Systemic Anti-Cancer Therapy Dataset in England. Clinical Oncology. 34(8). 497–507. 2 indexed citations

Walker, Julie, et al.. (2018). Perioperative ECX chemotherapy in older adults with gastroesophageal adenocarcinoma. Journal of Geriatric Oncology. 9(6). 569–574. 5 indexed citations

Evans, A.G., Richard Jackson, Victoria Shaw, et al.. (2018). Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or metastatic pancreatic carcinoma. Pancreatology. 18(4). S127–S128. 1 indexed citations

Neoptolemos, John P., Daniel H. Palmer, William Greenhalf, et al.. (2017). Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo-controlled trial in locally advanced or metastatic pancreatic carcinoma.. Journal of Clinical Oncology. 35(15_suppl). 4104–4104. 1 indexed citations

McDonnell, MJ, et al.. (2016). Gastrointestinal stromal tumours (GISTs): an insight into clinical practice with review of literature. Frontline Gastroenterology. 8(1). 19–25. 11 indexed citations

Seymour, Michel, Susan D. Richman, Gary Middleton, et al.. (2011). Addition of panitumumab to irinotecan: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC).. Journal of Clinical Oncology. 29(15_suppl). 3523–3523. 19 indexed citations

Braun, Michael, F. Adab, C. R. Bradley, et al.. (2003). Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer. British Journal of Cancer. 89(7). 1155–1158. 13 indexed citations

Wadd, Nick & H.H. Lucraft. (1998). Brachial plexus neuropathy following mantle radiotherapy. Clinical Oncology. 10(6). 399–400. 28 indexed citations

10.

Wadd, Nick, et al.. (1997). Cisplatin and acute tubular necrosis. Clinical Oncology. 9(4). 267–268. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact